- Investing Ideas
- /
- Software Healthcare Sector
Software Healthcare Sector
Results
2304
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2304 companies
Aclarion
Market Cap: US$3.9m
Operates as a healthcare technology company in the United States.
ACON
US$6.70
7D
-3.5%
1Y
-99.8%
Interpace Biosciences
Market Cap: US$3.9m
Provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States.
IDXG
US$0.87
7D
-2.2%
1Y
-40.9%
Enzolytics
Market Cap: US$3.9m
Enzolytics Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases.
ENZC
US$0.0008
7D
14.3%
1Y
-77.1%
Zelira Therapeutics
Market Cap: AU$5.9m
A biopharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based medicines for the treatment of a variety of medical conditions in Australia and the United States.
ZLD
AU$0.49
7D
23.8%
1Y
3.1%
MYND Life Sciences
Market Cap: CA$5.2m
A life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States.
MYND
CA$0.07
7D
0%
1Y
133.3%
InhaleRx
Market Cap: AU$5.8m
A biotechnology company, develops and sells registrable inhaled drug-device combinations in Australia.
IRX
AU$0.027
7D
8.0%
1Y
-10.0%
Aptevo Therapeutics
Market Cap: US$3.7m
A clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States.
APVO
US$0.28
7D
-13.9%
1Y
-99.0%
Willow Biosciences
Market Cap: CA$5.1m
Willow Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States.
WLLW
CA$0.035
7D
16.7%
1Y
-58.8%
Filament Health
Market Cap: US$3.7m
Operates as a clinical-stage natural psychedelic drug development company in Canada.
FLHL.F
US$0.014
7D
-15.6%
1Y
-53.0%
FinCanna Capital
Market Cap: CA$5.0m
Does not have significant operations.
CALI.X
CA$0.005
7D
0%
1Y
n/a
Aion Therapeutic
Market Cap: CA$5.0m
Engages in the health and wellness business in the United States.
AION
CA$0.01
7D
100.0%
1Y
-33.3%
XORTX Therapeutics
Market Cap: CA$5.0m
A late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat gout and progressive kidney disease.
XRTX
CA$1.31
7D
-9.0%
1Y
-62.6%
Tharimmune
Market Cap: US$3.6m
A clinical-stage biotechnology company, engages in the development of therapeutic candidates for rare, inflammatory, and oncologic conditions with high unmet need in the United States.
THAR
US$1.36
7D
2.1%
1Y
-70.3%
StageZero Life Sciences
Market Cap: CA$4.9m
A vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in North America and Western Europe.
SZLS
CA$0.04
7D
0%
1Y
-27.3%
Palisade Bio
Market Cap: US$3.5m
A clinical-stage biopharmaceutical company, focuses on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases.
PALI
US$0.81
7D
17.5%
1Y
-83.6%
Mosaic ImmunoEngineering
Market Cap: US$3.5m
A development-stage biotechnology company, focuses on advancing and commercialization of immunotherapies for the treatment of cancer.
CPMV
US$0.49
7D
-9.3%
1Y
16.3%
Lixte Biotechnology Holdings
Market Cap: US$3.5m
A clinical-stage biopharmaceutical company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies.
LIXT
US$1.32
7D
-4.3%
1Y
-45.7%
Applied DNA Sciences
Market Cap: US$3.5m
A biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally.
APDN
US$0.54
7D
-18.8%
1Y
-99.5%
VivoSim Labs
Market Cap: US$3.5m
A biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease.
VIVS
US$1.98
7D
-4.3%
1Y
-83.5%
Mystic Holdings
Market Cap: US$3.5m
Through its subsidiaries, engages in the cultivation, production, and wholesale of medical and recreational cannabis in Nevada, the United States.
MSTH
US$0.031
7D
-61.9%
1Y
-31.3%
Leveljump Healthcare
Market Cap: CA$4.8m
Provides radiology services.
JUMP
CA$0.05
7D
0%
1Y
-37.5%
Genetic Technologies
Market Cap: AU$5.7m
A molecular diagnostics company, engages in the provision of predictive genetic testing and risk assessment tools to help physicians manage people’s health in the America, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.
GTG
AU$0.039
7D
0%
1Y
-68.8%
Sonnet BioTherapeutics Holdings
Market Cap: US$3.5m
A biotechnology company, owns a platform for biologic medicines of single or bifunctional action.
SONN
US$1.13
7D
-12.4%
1Y
-91.4%
Roquefort Therapeutics
Market Cap: UK£2.6m
A material biotech company, engages in the development of medicines for the treatment of cancer.
ROQ
UK£0.017
7D
10.0%
1Y
-68.6%
SciSparc
Market Cap: US$3.5m
A clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies.
SPRC
US$0.31
7D
-2.7%
1Y
-72.8%
Adherium
Market Cap: AU$5.3m
Develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America.
ADR
AU$0.007
7D
-12.5%
1Y
-69.6%
GlucoTrack
Market Cap: US$3.4m
A medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States.
GCTK
US$0.13
7D
-11.2%
1Y
-99.7%
BSF Enterprise
Market Cap: UK£2.5m
Develops and commercializes cutting-edge tissue-engineered solutions.
BSFA
UK£0.02
7D
-8.0%
1Y
-57.4%
Xebra Brands
Market Cap: CA$4.6m
Engages in the cultivation, processing, manufacture, design, and delivery of cannabis products in Canada, Europe, and Mexico.
XBRA
CA$0.055
7D
22.2%
1Y
-45.0%
ProtoKinetix
Market Cap: US$3.3m
A research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs).
PKTX
US$0.0086
7D
-2.8%
1Y
-37.5%
4Front Ventures
Market Cap: CA$4.6m
Owns and manages licensed cannabis facilities in state-licensed markets in the United States.
FFNT
CA$0.005
7D
0%
1Y
-96.0%
Lobe Sciences
Market Cap: CA$4.6m
A biopharmaceutical company, engages in the research and development using sub-hallucinatory doses of proprietary psychedelic compounds to improve brain and mental health, and wellness in Canada.
LOBE
CA$0.025
7D
0%
1Y
66.7%
InMed Pharmaceuticals
Market Cap: US$3.3m
A clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States.
INM
US$2.76
7D
-6.4%
1Y
-54.5%
Biodexa Pharmaceuticals
Market Cap: US$3.3m
A clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of familial adenomatous polyposis, non-muscle invasive bladder cancer, and Type 1 diabetes and rare/orphan cancers of the brain.
BDRX
US$1.15
7D
-10.2%
1Y
-95.5%
NovaBay Pharmaceuticals
Market Cap: US$3.3m
Does not have significant operations.
NBY
US$0.57
7D
-3.4%
1Y
-87.7%
Kineta
Market Cap: US$3.3m
A clinical-stage biotechnology company, engages in developing immunotherapies that transform patients’ lives in the United States.
KANT
US$0.27
7D
-3.6%
1Y
-41.5%